Back to search
Extraocular Retinoblastoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Extraocular Retinoblastoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Extraocular Retinoblastoma trials you may qualify forThe goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in th…
This is a first in human dose escalation trial to determine the safety of administering GPC2 CAR T cells in patients with advanced neuroblastoma or retinoblasto…
Retinoblastoma is the most common intraocular malignancy in infancy and childhood. The overall survival rate of retinoblastoma was reported to exceed 95% when c…
This phase III trial is studying the side effects and how well giving combination chemotherapy together with autologous stem cell transplant and/or radiation th…
RATIONALE: Radiolabeled monoclonal antibodies, such as iodine I 131 monoclonal antibody 3F8, can find tumor cells and carry tumor-killing substances to them wit…